Advertisement

Index by author

October 01, 2024; Volume 52,Issue 10

  1. Banfield, Christopher

    1. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
      Jonathan N. Bauman, Angela C. Doran, Gabrielle M. Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A. Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S. Purohit and Martin E. Dowty
      Drug Metabolism and Disposition October 2024, 52 (10) 1124-1136; DOI: https://doi.org/10.1124/dmd.124.001843

  2. Bauman, Jonathan N.

    1. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
      Jonathan N. Bauman, Angela C. Doran, Gabrielle M. Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A. Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S. Purohit and Martin E. Dowty
      Drug Metabolism and Disposition October 2024, 52 (10) 1124-1136; DOI: https://doi.org/10.1124/dmd.124.001843

  3. Cerny, Matthew A.

    1. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
      Jonathan N. Bauman, Angela C. Doran, Gabrielle M. Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A. Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S. Purohit and Martin E. Dowty
      Drug Metabolism and Disposition October 2024, 52 (10) 1124-1136; DOI: https://doi.org/10.1124/dmd.124.001843

  4. Chen, Hao

    1. Open Access
      Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects
      Hao Chen, Abhi Shah, Suguru Kato, Robert Griffin, Steven Zhang, Sandeepraj Pusalkar, Lawrence Cohen, Yuexian Li, Swapan K. Chowdhury and Sean Xiaochun Zhu
      Drug Metabolism and Disposition October 2024, 52 (10) 1115-1123; DOI: https://doi.org/10.1124/dmd.124.001841

  5. Chowdhury, Swapan K.

    1. Open Access
      Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects
      Hao Chen, Abhi Shah, Suguru Kato, Robert Griffin, Steven Zhang, Sandeepraj Pusalkar, Lawrence Cohen, Yuexian Li, Swapan K. Chowdhury and Sean Xiaochun Zhu
      Drug Metabolism and Disposition October 2024, 52 (10) 1115-1123; DOI: https://doi.org/10.1124/dmd.124.001841

  6. Cohen, Lawrence

    1. Open Access
      Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects
      Hao Chen, Abhi Shah, Suguru Kato, Robert Griffin, Steven Zhang, Sandeepraj Pusalkar, Lawrence Cohen, Yuexian Li, Swapan K. Chowdhury and Sean Xiaochun Zhu
      Drug Metabolism and Disposition October 2024, 52 (10) 1115-1123; DOI: https://doi.org/10.1124/dmd.124.001841

  7. Cromwell, Christopher

    1. Development of a Novel HEK293 Cell Model Lacking <em>SLC29A1</em> to Study the Pharmacology of Endogenous <em>SLC29A2</em>-Encoded Equilibrative Nucleoside Transporter Subtype 2
      Open Access
      Development of a Novel HEK293 Cell Model Lacking SLC29A1 to Study the Pharmacology of Endogenous SLC29A2-Encoded Equilibrative Nucleoside Transporter Subtype 2
      Nayiar Shahid, Christopher Cromwell, Basil P. Hubbard and James R. Hammond
      Drug Metabolism and Disposition October 2024, 52 (10) 1094-1103; DOI: https://doi.org/10.1124/dmd.124.001814

  8. Doran, Angela C.

    1. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
      Jonathan N. Bauman, Angela C. Doran, Gabrielle M. Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A. Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S. Purohit and Martin E. Dowty
      Drug Metabolism and Disposition October 2024, 52 (10) 1124-1136; DOI: https://doi.org/10.1124/dmd.124.001843

  9. Dowty, Martin E.

    1. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
      Jonathan N. Bauman, Angela C. Doran, Gabrielle M. Gualtieri, Brian Hee, Timothy Strelevitz, Matthew A. Cerny, Christopher Banfield, Anna Plotka, Xiaoxing Wang, Vivek S. Purohit and Martin E. Dowty
      Drug Metabolism and Disposition October 2024, 52 (10) 1124-1136; DOI: https://doi.org/10.1124/dmd.124.001843

  10. Du, Anqi

    1. Methyltransferase Like-3–Mediated N6-Methyladenosine Modification of Long Noncoding RNA Hepatocyte Nuclear Factor 1a Antisense RNA 1/Hepatocyte Nuclear Factor 4a Antisense RNA 1 Regulates Cytochrome P450 Enzyme Expression
      Methyltransferase Like-3–Mediated N6-Methyladenosine Modification of Long Noncoding RNA Hepatocyte Nuclear Factor 1a Antisense RNA 1/Hepatocyte Nuclear Factor 4a Antisense RNA 1 Regulates Cytochrome P450 Enzyme Expression
      Yihang Yu, Jingya Wang, Zaihuan Xiong, Anqi Du, Xiaofei Wang, Yiting Wang, Shengna Han, Pei Wang and Lirong Zhang
      Drug Metabolism and Disposition October 2024, 52 (10) 1104-1114; DOI: https://doi.org/10.1124/dmd.124.001832
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top

In this issue

Advertisement